香港不明原因慢性肾脏病的全基因组测序研究
本研究前瞻性纳入香港131例不明原因慢性肾脏病(CKDx)成人患者,行637个肾病基因的全基因组测序,诊断率为10%,Alport谱系疾病占遗传阳性病例的77%,阳性者家族史比例显著更高。
要点
- 成人CKDx患者全基因组测序诊断率为10%。
- Alport谱系疾病是最常见遗传诊断,占阳性病例77%。
- 阳性遗传 Findings 者CKD或CKDx家族史比例显著更高。
核心结论
- 香港成人CKDx患者中10%可确立单基因病因。
- Alport谱系疾病是最常见遗传诊断,其次为非典型常染色体显性多囊肾病和肾单位肾痨。
- 对CKDx人群进行基因检测具有临床实用性,相当比例可获诊断并指导疾病特异性管理。
研究设计与样本
- 前瞻性队列研究,2022年10月1日至2024年6月1日在玛丽医院肾内科招募成人CKDx患者。
- 经遗传咨询后行聚焦637个肾病基因的全基因组测序,变异分类依据美国医学遗传学与基因组学学会指南。
- 共纳入131例CKDx患者,92%自我认同为中国人,21%表现为肾衰竭,平均临床发病年龄35岁,36%有CKD家族史。
主要发现
- 在131例患者中鉴定出致病/可能致病变异13例,诊断率为10%。
- 所鉴定变异的33%为新发变异。
- Ⅳ型胶原基因(COL4A3、COL4A5、COL4A4)变异最常见,其次为ALG9、CEP290和IFT140。
- Alport谱系疾病占所有遗传阳性病例的77%。
- 遗传阳性者CKD家族史比例显著高于阴性者(85% vs 31%,p<0.001),CKDx家族史比例亦显著更高(77% vs 19%,p<0.001)。
临床怎么用
- 对标准诊断流程后仍不明原因的成人CKD患者,可考虑行肾病基因 panel 或全基因组测序。
- 详细采集CKD/CKDx家族史有助于筛选遗传检测优势人群。
- 基因诊断可明确Alport谱系疾病等单基因病因,并指导疾病特异性管理。
局限性
- 单中心前瞻性研究,样本量131例,结论外推需谨慎。
- 仅聚焦637个肾病基因,可能遗漏未纳入 panel 的致病基因。
- 摘要未报告随访时长及基因诊断对硬终点的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant proportion of patients present with chronic kidney disease of unexplained cause (CKDx) despite standard-of-care diagnostic workup. Data from Australian, European and United States cohorts show that some are due to monogenic etiology. The diagnostic yield and clinical utility of genetic testing in Chinese patients remains unclear. METHODS: We prospectively recruited adult CKDx patients following up at Queen Mary Hospital nephrology unit from 1 Oct 2022 to 1 June 2024. After genetic counselling, patients underwent whole genome sequencing focused on kidney disease genes(637 genes). Variants classification was performed according to the American College of Medical Genetics guidelines. RESULTS: Among 131 CKDx patients, 92% self-identified as Chinese and 21% presented with kidney failure. Mean age at clinical presentation was 35 years. 36% had positive family history of CKD. We identified Pathogenic/Likely pathogenic variants in 13 patients, giving a diagnostic yield of 10%. 33% of variants identified were novel. Variants in type IV collagen genes(COL4A3, COL4A5, COL4A4) were the most frequent, followed by ALG9, CEP290 and IFT140. Alport-spectrum disorders were the leading genetic diagnoses, representing 77% of all genetically positive cases. A significantly higher proportion of patients with positive genetic findings had positive family history of CKD or CKDx, compared to those with negative genetic findings (CKD: 85% versus 31%, p<0.001; CKDx: 77% versus 19%, p<0.001). CONCLUSIONS: Monogenic etiology could be established in 10% of adult CKDx patients in Hong Kong. Alport-spectrum disorders were the leading genetic diagnoses, followed by atypical Autosomal Dominant Polycystic Kidney Disease and nephronophthisis. Genetic testing in CKDx population is clinically useful since a significant proportion could reach a diagnosis and permit disease specific management.
引用
- Ma BM, Hue SPY, Ma W, et al. Whole genome sequencing for CKD of unexplained cause in Hong Kong. Nephrol Dial Transplant. 2026. PMID: 42329778. doi:10.1093/ndt/gfag148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。